Christophe Weber
-
Takeda group begins manufacturing COVID-19 plasma treatment ahead of approval
The Takeda Pharmaceutical Co-led group that is developing a blood plasma treatment for COVID-19 has started manufacturing while the late-stage trial to determine…
Read More »